Moving the Needle From Cost to Value
Global market dynamics have created the need for a new compliance model – one that delivers an integrated solution across compliance, from molecule to market, and beyond. EVERSANA’s experts are transforming the industry by delivering deep domain expertise, innovative technology, and advanced data and analytics to ensure the safety and efficacy of clients’ products. By moving the compliance needle from a cost center to a value insights and strategy model, our clients stay focused on what matters most: helping patients live healthier lives.
Advancing Life Sciences Compliance to Deliver Safer Products
Medical science capabilities are an integral component of EVERSANA’s compliance model. Our integrated global approach comprises four major services – Pharmacovigilance, Medical Information, Quality Assurance & Quality Systems, and Regulatory – together acting as one partner providing commercial life sciences solutions across the product life cycle.
Our holistic model delivers the next generation of safer and better products, focused on weaving five value-creation areas throughout the compliance paradigm. Integrating an enterprise-wide view of compliance risk, supported by a compliance committee, results in a proactive compliance value system of competitive advantages designed to improve patient safety.
We support our customers across the product life cycle, and with our flexible delivery model we can deliver an integrated and centralized compliance monitoring center across Pharmacovigilance, Medical Affairs, Regulatory and Quality; or we can support customers in just one of these process areas. In terms of the value-creation paradigm, we support our customers at the operation level – ensuring ongoing regulatory compliance to help them create true value through proactive and predictive data analytics in order to deliver on all five value-creation areas.
